Join our Hematology/Oncology team at Buffett Cancer Center. @NebraskaMed @UNMCHemeOnc . Faculty positions available for non-Malignant Hematology, BMT, Leukemia, Multiple Myeloma, as well as Section Leader for non-malignant Hematology. Contact me for info!
Doctors tend to avoid litigation
…and they really, really want to avoid indictment.
Hot take for states:
you should also consider the effects that new policies will have on recruitment/retention of clinicians--of all types, at all stages.
https://t.co/GpkOHU226U
I believe in the power of music to buoy the human spirit
A patient informed me they measure the duration of their treatments by Taylor Swift songs, which I think is an amazing unit of measurement !
Here’s to getting an Eras Tour-length playlist down to the point when they can
Outstanding poster presentation by UNMC med student @MGromowsky and congrats on ASH abstract award with co-auths @nsc_natalie@MdZhubin on our work on the impact of antibiotics on outcomes post transplant in myeloma! Could be gut microbiota related?? 🤔🤓 #ASH22@UNMCHemeOnc
Outstanding scientific session on dietary evidence for intervention in heme malignancies! great talks by @UrviShahMD Dr Marinac and Dr. Bellone, growing scientific rationale and strong patient interest. Packed audience too! #ASH22#llsm#mmsm
There is time to contribute to special issue on "Pathogenesis & Molecular Therapy of #Lymphoid Malignancies" @IJMS_MDPI! #Leukaemia#Lymphoma#Myeloma hosted by Dr. D’Angelo @crdangelo9 & I. Great articles in line! Deadline is 1/31/2023. For more details: https://t.co/dj63PTWeMU
Join me and co-guest editor @DrDaliaElgamal on the @IJMS_MDPI IF 6.2! special issue on molecular pathogenesis and therapy in lynphoid malignancies! Submit your work today! #mmsm#lymphoma#leukemia
👇first paper
https://t.co/ojJE2EKT3T
👇 Link
https://t.co/ojJE2EKT3T
Announcing a special issue covering the "Pathogenesis & Molecular Therapy of #Lymphoid Malignancies" @IJMS_MDPI!Consider submitting your work or an abstract soon! #Leukaemia#Lymphoma#Myeloma
Special Issue link:
https://t.co/dj63PTVGXm